Connection

Daynna Wolff to Genetic Testing

This is a "connection" page, showing publications Daynna Wolff has written about Genetic Testing.
Connection Strength

0.687
  1. Guidance for fluorescence in situ hybridization testing in hematologic disorders. J Mol Diagn. 2007 Apr; 9(2):134-43.
    View in: PubMed
    Score: 0.277
  2. Developing a sustainable process to provide quality control materials for genetic testing. Genet Med. 2005 Oct; 7(8):534-49.
    View in: PubMed
    Score: 0.249
  3. Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories. Genet Med. 2005 Jul-Aug; 7(6):444-53.
    View in: PubMed
    Score: 0.061
  4. Cryptic and atypical KMT2A-USP2 and KMT2A-USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia. Genes Chromosomes Cancer. 2020 07; 59(7):422-427.
    View in: PubMed
    Score: 0.043
  5. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn. 2017 01; 19(1):4-23.
    View in: PubMed
    Score: 0.034
  6. American College of Medical Genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays intended for use in the postnatal setting for detection of constitutional abnormalities. Genet Med. 2011 Jul; 13(7):676-9.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.